LEADER 00832nam0-22002891i-450 001 990003065560403321 005 20190516112117.0 010 $a0-226-24088-6 100 $a20030910d1987----km-y0itay50------ba 101 0 $aeng 102 $aIT 200 1 $a<>Effects of Taxation on Capital Accumulation$fedited by Martin Feldstein. 210 $aChicago$aLondon$cUniversity of Chicago Press$d1987. 215 $a490 p.$d24 cm 676 $aN/2.311 702 1$aFeldstein,$bMartin$f<1939- > 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003065560403321 952 $aN/2.311 FEL/N.A.$b8915$fSES 952 $aXV T 82$b8579$fDTE 952 $aH2.72$b720$fDECTS 959 $aSES 959 $aDECTS 959 $aDTE 996 $aEffects of Taxation on Capital Accumulation$9464716 997 $aUNINA LEADER 02323nam 2200469z- 450 001 9910220046503321 005 20210211 035 $a(CKB)3800000000216312 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/51895 035 $a(oapen)doab51895 035 $a(EXLCZ)993800000000216312 100 $a20202102d2016 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aLiver Myofibroblasts 210 $cFrontiers Media SA$d2016 215 $a1 online resource (99 p.) 225 1 $aFrontiers Research Topics 311 08$a2-88919-989-4 330 $aMyofibroblasts (MFB) are found in most tissues of the body. They have the matrix-producing functions of fibroblasts and contractile properties that are known from smooth muscle cells. Fundamental work of the last decades has shed remarkable light on their origin, biological functions and role in disease. During hepatic injury, they fulfill manifold functions in connective tissue remodeling and wound healing, but overshooting activity of MFB on the other side induces fibrosis and cirrhosis. The present e-book "Liver myofibroblasts" contains 9 articles providing comprehensive information on "hot topics" of MFB. In our opening editorial we provide a short overview of the origin of MFB and their relevance in extracellular matrix formation which is the hallmark of hepatic fibrosis. Thereafter, leading experts in the field share their current perspectives on special topics of (i) MFB in development and disease, ii) their role in hepatic fibrogenesis, and (iii) promising therapies and targets that are suitable to interfere with hepatic fibrosis. 606 $aPhysiology$2bicssc 610 $aAutophagy 610 $aCytoglobin 610 $aHepatic Stellate Cells 610 $aMatrix stiffness 610 $amiRNA 610 $aMyofibroblasts 610 $aNADPH Oxidase 610 $aPortal myofibroblasts 610 $atherapy 610 $aXanthohumol 615 7$aPhysiology 700 $aJiri Kanta$4auth$01315284 702 $aAlena Mrkvicova$4auth 702 $aRalf Weiskirchen$4auth 906 $aBOOK 912 $a9910220046503321 996 $aLiver Myofibroblasts$93032338 997 $aUNINA